Microangiopathic Hemolytic Anemia (MAHA)
USMLE Step 1 trap: Confuses mechanical RBC shearing (MAHA) with immune-mediated hemolysis as the cause of schistocytes. Schistocytes in MAHA result from mechanical shearing of RBCs as they pass through fibrin strands or damaged microvasculature.
Microangiopathic hemolytic anemia (MAHA) is a specific form of hemolytic anemia caused by physical destruction of red blood cells as they're forced through narrowed, fibrin-clogged, or mechanically turbulent small vessels. USMLE Step 1 will show you a clinical vignette with anemia, thrombocytopenia, and a smear with schistocytes, and you need to identify both the mechanism and the underlying cause. The critical misconception to fix first: students assume that all MAHA causes consume clotting factors, but TTP and HUS have normal PT/PTT — only DIC extends coagulation times. That single distinction separates most MAHA questions on the exam.
The exam tests MAHA from two angles: the mechanism of RBC fragmentation (why schistocytes form and what labs follow), and the differential between consumptive versus non-consumptive etiologies (how TTP/HUS differ from DIC in coagulation studies). The passage will often give you enough clues — platelet count, PT/PTT, fibrinogen, clinical context — to distinguish these. The skill isn't just recognizing MAHA; it's using coag labs to narrow the etiology.
What trips students up most is conflating mechanical hemolysis with immune hemolysis (they look similar on CBC but differ on smear and Coombs), and assuming all MAHA causes deplete clotting factors. They don't. TTP and HUS have normal PT/PTT — that's the key distinguishing feature on USMLE Step 1. The other gap is forgetting that MAHA isn't just TTP and HUS. Malignant hypertension, HELLP syndrome, DIC, and prosthetic heart valves all cause the same smear picture.
Common misconceptions
What the exam tests
- Understand the mechanical shearing mechanism: RBCs are physically torn apart by fibrin strands or damaged microvasculature, producing schistocytes — this is distinct from immune-mediated hemolysis, which would show a positive Coombs test instead.
- Interpret the peripheral smear correctly: schistocytes (helmet cells, fragmented RBCs) plus thrombocytopenia should immediately trigger MAHA as your diagnosis framework before you consider the etiology.
- Distinguish consumptive MAHA (DIC: elevated PT/PTT, low fibrinogen, low platelets, high D-dimer) from non-consumptive MAHA (TTP/HUS: normal PT/PTT, normal fibrinogen, low platelets — coagulation cascade is intact).
- Know the full differential of MAHA causes: TTP (ADAMTS13 deficiency), HUS (Shiga toxin, complement), DIC (sepsis, malignancy, obstetric emergencies), HELLP syndrome, malignant hypertension, and prosthetic valve hemolysis — and what clinical context points to each.
Can you avoid these mistakes?
Related topics
See how your Anki deck covers this topic.
Upload your deck for a free audit →